BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18067104)

  • 1. Newer strategies for anemia prevention in hemodialysis.
    Handelman GJ
    Int J Artif Organs; 2007 Nov; 30(11):1014-9. PubMed ID: 18067104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insight on vitamin C in patients with chronic kidney disease.
    Handelman GJ
    J Ren Nutr; 2011 Jan; 21(1):110-2. PubMed ID: 21195931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients.
    Keven K; Kutlay S; Nergizoglu G; Ertürk S
    Am J Kidney Dis; 2003 Jun; 41(6):1233-9. PubMed ID: 12776276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant status and lipid peroxidation in hemodialysis patients undergoing erythropoietin and erythropoietin-vitamin E combined therapy.
    Inal M; Kanbak G; Sen S; Akyüz F; Sunal E
    Free Radic Res; 1999 Sep; 31(3):211-6. PubMed ID: 10499778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency.
    Sultana T; DeVita MV; Michelis MF
    Int Urol Nephrol; 2016 Sep; 48(9):1519-24. PubMed ID: 27170339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is vitamin C intake too low in dialysis patients?
    Raimann JG; Levin NW; Craig RG; Sirover W; Kotanko P; Handelman G
    Semin Dial; 2013; 26(1):1-5. PubMed ID: 23106569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
    Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
    Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correcting iron-restricted erythropoiesis and improving anemia in patients on hemodialysis: practical tips that can make a difference.
    Easom A
    Nephrol Nurs J; 2009; 36(5):529-37, 553. PubMed ID: 19856814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjusting i.v. iron and EPO doses in patients on hemodialysis prior to continuing surgery: can we protect our patients education from iron-deficiency anemia?
    Deaver K; Bennington L
    Nephrol Nurs J; 2006; 33(4):430-7; quiz 438. PubMed ID: 17002001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload.
    Lin CL; Hsu PY; Yang HY; Huang CC
    Ren Fail; 2003 May; 25(3):445-53. PubMed ID: 12803508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma vitamin C levels in ESRD patients and occurrence of hypochromic erythrocytes.
    Seibert E; Richter A; Kuhlmann MK; Wang S; Levin NW; Kotanko P; Handelman GJ
    Hemodial Int; 2017 Apr; 21(2):250-255. PubMed ID: 27619554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-effectiveness analysis of anemia screening before erythropoietin in patients with end-stage renal disease.
    Hutchinson FN; Jones WJ
    Am J Kidney Dis; 1997 May; 29(5):651-7. PubMed ID: 9159297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of anemia associated with chronic renal disease: primary and secondary mechanisms.
    Paganini EP
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):3-8. PubMed ID: 2648518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Anemia Management in Hemodialysis Patients with Cancer.
    Butler AM; Kshirsagar AV; Olshan AF; Nielsen ME; Wheeler SB; Brookhart MA
    Am J Nephrol; 2015; 42(3):206-15. PubMed ID: 26439712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.